Petri is a new approach for funding formation-stage startups at the intersection of biology and engineering. Petri is co-founded by entrepreneurs who have built iconic companies as well as academics who are driving foundational science in bioengineering; together we have deep experience developing ideas into successful companies across human health and sustainability. We invest pre-seed and seed capital and work one-on-one with founders for 12+ months. We help founders build world-class teams, develop intellectual property, find customers, and raise a subsequent round of financing.
Location: United States, Massachusetts, Boston
Employees: 1-10
Founded date: 2019
Investors 1
Mentions in press and media 9
| Date | Title | Description |
| 07.09.2021 | Meet Dr. Tony Kulesa, founder and Partner at Petri | Petri, which is funded by Pillar VC, focuses on helping scientists start companies Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there are more ... |
| 09.09.2020 | BostInno Approved: September's top virtual tech and startup events | September always signals the start of something new: the school year, a new season and the shift in attitude that comes with those changes. Things look a little bit different this year because of the ongoing coronavirus pandemic. But there ... |
| 27.09.2019 | How To Spot A Synthetic Biology Unicorn | Biotech is projected to reach $775 billion by 2024, but dozens of companies in the field of ... [+] synthetic biology are creating magical tools to go beyond that. Look here for the next unicorn. Jelena Trmčić for SynBioBeta |
| 13.09.2019 | Petri launches year-long accelerator for startups that combine biology, tech, and engineering | The frontier of biology is being driven by technology, which happens to be the specialty of Petri, a Boston-based accelerator program that targets startups mixing biology, engineering, and technology. Petri is offering PhDs and postdocs fro... |
| 13.09.2019 | Pillar ponies up for Petri, Boston's new accelerator for fledgling biotechs | Pillar, a Boston-based venture capital firm, is bankrolling a new accelerator for budding biotechs. Named Petri, the accelerator aims to serve a group left behind by life sciences- and health IT-focused VC firms—startups at the “frontier of... |
| 13.09.2019 | Boston gets a new biotech accelerator with the launch of Petri | As biotechnology becomes more central to new innovations in healthcare, material science and manufacturing, one of the nation’s research hubs is getting a new accelerator called Petri to launch companies focused on the commercialization of ... |
| 13.09.2019 | Pillar ponies up for Petri, Boston's new accelerator for fledgling biotechs | Pillar, a Boston-based venture capital firm, is bankrolling a new accelerator for budding biotechs. Named Petri, the accelerator aims to serve a group left behind by life sciences- and health IT-focused VC firms—startups at the “frontier of... |
| 13.09.2019 | Petri launches year-long accelerator for startups that combine biology, tech, and engineering | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! The frontier of biology is being driven by techno... |
| - | Java Jolt: Could climate change kill your coffee buzz? Say hello to Compound Foods | Every day, millions of people around the world wake up and engage in a ritual that’s nearly as old as mankind itself: drinking coffee. In the U.S. alone, Americans consume 656 million cups of java juice on the daily, and 35% of us keep righ... |